Usona Institute Seeks DEA Bulk Controlled Substance Manufacturer Registration
Summary
Usona Institute Seeks DEA Bulk Controlled Substance Manufacturer Registration
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Content
ACTION:
Notice of application.
SUMMARY:
Usona Institute, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer
to
SUPPLEMENTARY INFORMATION
listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on
or objections to the issuance of the proposed registration on or before June 16, 2026. Such persons may also file a written
request for a hearing on the application on or before June 16, 2026.
ADDRESSES:
The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file
for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive
a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit
the same comment.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on March 2, 2026, Usona Institute, Inc., 2780 Woods Hollow Road,
Room 2412-2413, Fitchburg, Wisconsin 53711, applied to be registered as a bulk manufacturer of the following basic class(es)
of controlled substance(s):
| Controlled substance | Drug code | Schedule |
|---|---|---|
| 5-Methoxy-N-N-dimethyltryptamine | 7431 | I |
| Psilocybin | 7437 | I |
| Psilocyn | 7438 | I |
The company plans to manufacture the listed controlled substances for use in chemical process development as well as pre-clinical
and clinical research. No other activities for these drug codes are authorized for this registration.
Thomas Prevoznik, Deputy Assistant Administrator. [FR Doc. 2026-07562 Filed 4-16-26; 8:45 am] BILLING CODE P
Download File
Related changes
Get daily alerts for Regs.gov: Drug Enforcement Administration
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from DEA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Browse Categories
Get alerts for this source
We'll email you when Regs.gov: Drug Enforcement Administration publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.